CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
Indianapolis, Indiana, United States and 19 other locations
therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...
Phase 2
Indianapolis, Indiana, United States and 27 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Indianapolis, Indiana, United States and 9 other locations
carboplatin monotherapy vs. carboplatin combined with tocilizumab in in Black and non-Black patients with metastatic triple negative or ER low breast...
Phase 2
Indianapolis, Indiana, United States and 3 other locations
This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast...
Phase 2
Indianapolis, Indiana, United States and 6 other locations
The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and a ...
Phase 2
Indianapolis, Indiana, United States and 17 other locations
This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...
Phase 2
Indianapolis, Indiana, United States and 16 other locations
works in treating patients with stage IV triple negative breast cancer. Drugs used in chemotherapy, such as carboplatin, work in di...
Phase 2
Indianapolis, Indiana, United States and 5 other locations
evaluate the efficacy of this combination in advanced HER2 negative breast cancer that is triple negative or BRCA1/2 positive (defi...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 4 other locations
Breast cancer is the most common malignancy in the U.S. Targeted therapies such as tamoxifen have been revolutionary in reducing tu ...
Phase 2
Indianapolis, Indiana, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal